BACKGROUND: We conducted a cost of illness study to assess the economic burden of pediatric enteric fever (typhoid and paratyphoid) in Bangladesh. Results can inform public health policies to prevent enteric fever. METHODS: The study was conducted at 2 pediatric health facilities in Dhaka. For the patient and caregiver's perspective, we administered questionnaires on costs incurred from illness onset until the survey dates to caregivers of patients with blood culture positive cases at enrollment and 6 weeks later to estimate the direct medical, direct nonmedical, and indirect costs. From the perspective of the health care provider, we collected data on quantities and prices of resources used by the 2 hospitals to estimate the direct medical economic costs to treat a case of enteric fever. We collected costs in Bangladeshi takas and converted them into 2018 US dollars. We multiplied the unit cost per procedure by the frequency of procedures in the surveillance case cohort to calculate the average cost per case. RESULTS: Among the 1772 patients from whom we collected information, the median cost of illness per case of enteric fever from the patient and caregiver perspective was US $64.03 (IQR: US $33.90 -$173.48). Median direct medical and nonmedical costs per case were 3% of annual labor income across the sample. From the perspective of the healthcare provider, the average direct medical cost per case was US $58.64 (range: US $37.25 at Hospital B, US $73.27 at Hospital A). CONCLUSIONS: Our results show substantial economic burden of enteric fever in Bangladesh, with higher costs for patients receiving inpatient care. As antimicrobial resistance increases globally, the cost of illness could increase, due to more expensive and potent drugs required for treatment.
BACKGROUND: We conducted a cost of illness study to assess the economic burden of pediatric enteric fever (typhoid and paratyphoid) in Bangladesh. Results can inform public health policies to prevent enteric fever. METHODS: The study was conducted at 2 pediatric health facilities in Dhaka. For the patient and caregiver's perspective, we administered questionnaires on costs incurred from illness onset until the survey dates to caregivers of patients with blood culture positive cases at enrollment and 6 weeks later to estimate the direct medical, direct nonmedical, and indirect costs. From the perspective of the health care provider, we collected data on quantities and prices of resources used by the 2 hospitals to estimate the direct medical economic costs to treat a case of enteric fever. We collected costs in Bangladeshi takas and converted them into 2018 US dollars. We multiplied the unit cost per procedure by the frequency of procedures in the surveillance case cohort to calculate the average cost per case. RESULTS: Among the 1772 patients from whom we collected information, the median cost of illness per case of enteric fever from the patient and caregiver perspective was US $64.03 (IQR: US $33.90 -$173.48). Median direct medical and nonmedical costs per case were 3% of annual labor income across the sample. From the perspective of the healthcare provider, the average direct medical cost per case was US $58.64 (range: US $37.25 at Hospital B, US $73.27 at Hospital A). CONCLUSIONS: Our results show substantial economic burden of enteric fever in Bangladesh, with higher costs for patients receiving inpatient care. As antimicrobial resistance increases globally, the cost of illness could increase, due to more expensive and potent drugs required for treatment.
Authors: Arthorn Riewpaiboon; Moritz Piatti; Benedikt Ley; Jacqueline Deen; Kamala Thriemer; Lorenz von Seidlein; Mohammad Salehjiddawi; Clara Jana-Lui Busch; Wolfgang H Schmied; Said Mohammed Ali Journal: J Health Popul Nutr Date: 2014-09 Impact factor: 2.000
Authors: Senjuti Saha; Md Shfiqul Islam; Mohammad Saiful Islam Sajib; Shampa Saha; Mohammad Jamal Uddin; Yogesh Hooda; Md Hasan; Md Ruhul Amin; Mohammed Hanif; Mohammad Shahidullah; Maksuda Islam; Stephen P Luby; Jason R Andrews; Samir K Saha Journal: Clin Infect Dis Date: 2019-03-07 Impact factor: 9.079
Authors: Denise O Garrett; Ashley T Longley; Kristen Aiemjoy; Mohammad T Yousafzai; Caitlin Hemlock; Alexander T Yu; Krista Vaidya; Dipesh Tamrakar; Shampa Saha; Isaac I Bogoch; Kashmira Date; Senjuti Saha; Mohammad Shahidul Islam; K M Ishtiaque Sayeed; Caryn Bern; Sadia Shakoor; Irum F Dehraj; Junaid Mehmood; Mohammad S I Sajib; Maksuda Islam; Rozina S Thobani; Aneeta Hotwani; Najeeb Rahman; Seema Irfan; Shiva R Naga; Ashraf M Memon; Sailesh Pradhan; Khalid Iqbal; Rajeev Shrestha; Hafizur Rahman; Md Mahmudul Hasan; Saqib H Qazi; Abdul M Kazi; Nasir S Saddal; Raza Jamal; Mohammed J Hunzai; Tanvir Hossain; Florian Marks; Alice S Carter; Jessica C Seidman; Farah N Qamar; Samir K Saha; Jason R Andrews; Stephen P Luby Journal: Lancet Glob Health Date: 2022-07 Impact factor: 38.927
Authors: Pritimoy Das; M Ziaur Rahman; Sayera Banu; Mahmudur Rahman; Mohammod Jobayer Chisti; Fahmida Chowdhury; Zubair Akhtar; Anik Palit; Daniel W Martin; Mahabub Ul Anwar; Angella Sandra Namwase; Pawan Angra; Cecilia Y Kato; Carmen J Ramos; Joseph Singleton; Jeri Stewart-Juba; Nikita Patel; Marah Condit; Ida H Chung; Renee Galloway; Michael Friedman; Adam L Cohen Journal: PLoS One Date: 2022-09-01 Impact factor: 3.752